HCA Healthcare (1HCA) Ratios
HCA Healthcare Ratios
IT:1HCA's free cash flow for Q3 2026 was $3.10B. For the 2026 fiscal year, IT:1HCA's free cash flow was decreased by $-1.36B and operating cash flow was $4.46B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.83 | 1.08 | 1.18 | 1.38 | 1.41 |
| Quick Ratio | 0.73 | 0.97 | 1.02 | 1.17 | 1.21 |
| Cash Ratio | 0.06 | 0.13 | 0.07 | 0.09 | 0.15 |
| Solvency Ratio | 0.16 | 0.15 | 0.15 | 0.16 | 0.20 |
| Operating Cash Flow Ratio | 0.77 | 0.69 | 0.75 | 0.86 | 0.93 |
| Short-Term Operating Cash Flow Coverage | 1.87 | 2.24 | 3.89 | 23.03 | 37.80 |
| Net Current Asset Value | $ -49.93B | $ -42.54B | $ -40.22B | $ -38.87B | $ -35.71B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.83 | 0.76 | 0.74 | 0.77 | 0.72 |
| Debt-to-Equity Ratio | -8.33 | -18.10 | -23.60 | -14.53 | -39.36 |
| Debt-to-Capital Ratio | 1.14 | 1.06 | 1.04 | 1.07 | 1.03 |
| Long-Term Debt-to-Capital Ratio | 1.17 | 1.07 | 1.05 | 1.08 | 1.03 |
| Financial Leverage Ratio | -10.07 | -23.81 | -31.69 | -18.95 | -54.39 |
| Debt Service Coverage Ratio | 1.51 | 1.78 | 2.55 | 5.47 | 6.87 |
| Interest Coverage Ratio | 5.32 | 5.12 | 4.97 | 5.21 | 6.33 |
| Debt to Market Cap | 0.45 | 0.55 | 0.54 | 0.54 | 0.41 |
| Interest Debt Per Share | 227.32 | 182.90 | 160.78 | 144.44 | 118.32 |
| Net Debt to EBITDA | 3.15 | 3.12 | 3.22 | 2.96 | 2.48 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.50% | 40.62% | 39.37% | 38.48% | 38.28% |
| EBIT Margin | 15.98% | 14.99% | 14.84% | 17.14% | 19.40% |
| EBITDA Margin | 20.64% | 19.68% | 19.58% | 22.06% | 24.26% |
| Operating Profit Margin | 15.83% | 14.94% | 14.82% | 15.03% | 16.47% |
| Pretax Profit Margin | 13.01% | 12.07% | 11.86% | 14.24% | 16.74% |
| Net Profit Margin | 8.97% | 8.16% | 8.07% | 9.37% | 11.84% |
| Continuous Operations Profit Margin | 10.29% | 9.43% | 9.38% | 11.35% | 13.14% |
| Net Income Per EBT | 69.00% | 67.58% | 68.02% | 65.77% | 70.74% |
| EBT Per EBIT | 82.17% | 80.81% | 80.05% | 94.78% | 101.60% |
| Return on Assets (ROA) | 11.17% | 9.68% | 9.33% | 10.76% | 13.71% |
| Return on Equity (ROE) | -112.56% | -230.49% | -295.49% | -203.94% | -745.55% |
| Return on Capital Employed (ROCE) | 26.97% | 23.79% | 22.10% | 21.28% | 23.51% |
| Return on Invested Capital (ROIC) | 18.53% | 16.68% | 16.42% | 16.66% | 18.18% |
| Return on Tangible Assets | 13.45% | 11.66% | 11.33% | 13.19% | 16.88% |
| Earnings Yield | 6.30% | 7.42% | 7.11% | 8.10% | 8.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.96 | 6.57 | 6.52 | 6.77 | 7.26 |
| Payables Turnover | 9.49 | 9.80 | 9.31 | 8.74 | 8.82 |
| Inventory Turnover | 26.77 | 24.12 | 19.49 | 17.92 | 18.26 |
| Fixed Asset Turnover | 2.43 | 2.24 | 2.17 | 2.18 | 2.24 |
| Asset Turnover | 1.25 | 1.19 | 1.16 | 1.15 | 1.16 |
| Working Capital Turnover Ratio | -97.30 | 40.24 | 21.61 | 15.64 | 15.48 |
| Cash Conversion Cycle | 27.65 | 33.48 | 35.45 | 32.49 | 28.90 |
| Days of Sales Outstanding | 52.47 | 55.58 | 55.95 | 53.88 | 50.29 |
| Days of Inventory Outstanding | 13.63 | 15.13 | 18.73 | 20.37 | 19.99 |
| Days of Payables Outstanding | 38.45 | 37.23 | 39.23 | 41.75 | 41.38 |
| Operating Cycle | 66.10 | 70.71 | 74.67 | 74.25 | 70.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 54.77 | 40.66 | 34.62 | 29.35 | 27.71 |
| Free Cash Flow Per Share | 33.34 | 21.81 | 17.21 | 14.21 | 16.65 |
| Dividend Paid and CapEx Coverage Ratio | 2.25 | 1.89 | 1.74 | 1.69 | 2.13 |
| Capital Expenditure Coverage Ratio | 2.56 | 2.16 | 1.99 | 1.94 | 2.50 |
| Operating Cash Flow Coverage Ratio | 0.25 | 0.23 | 0.23 | 0.21 | 0.24 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.15 | 0.15 | 0.14 | 0.15 |
| Free Cash Flow Yield | 7.14% | 7.26% | 6.36% | 5.92% | 6.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.31 | 13.48 | 14.07 | 12.35 | 11.94 |
| Price-to-Sales (P/S) Ratio | 1.42 | 1.10 | 1.13 | 1.16 | 1.41 |
| Price-to-Book (P/B) Ratio | -17.87 | -31.06 | -41.56 | -25.18 | -89.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.00 | 13.76 | 15.73 | 16.88 | 15.43 |
| Price-to-Operating Cash Flow Ratio | 8.52 | 7.38 | 7.82 | 8.18 | 9.27 |
| Price-to-Earnings Growth (PEG) Ratio | 0.57 | 0.86 | -13.67 | -1.28 | 0.13 |
| Enterprise Value Multiple | 10.05 | 8.70 | 9.01 | 8.20 | 8.30 |
| Enterprise Value | 156.87B | 120.92B | 114.66B | 108.96B | 118.34B |
| EV to EBITDA | 10.05 | 8.70 | 9.01 | 8.20 | 8.30 |
| EV to Sales | 2.07 | 1.71 | 1.76 | 1.81 | 2.01 |
| EV to Free Cash Flow | 20.39 | 21.44 | 24.46 | 26.40 | 21.99 |
| EV to Operating Cash Flow | 12.41 | 11.50 | 12.16 | 12.79 | 13.21 |
| Tangible Book Value Per Share | -56.63 | -36.88 | -32.62 | -33.50 | -24.90 |
| Shareholders’ Equity Per Share | -26.12 | -9.66 | -6.51 | -9.53 | -2.89 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.22 | 0.21 | 0.20 | 0.21 |
| Revenue Per Share | 327.68 | 273.02 | 238.50 | 207.45 | 181.72 |
| Net Income Per Share | 29.40 | 22.27 | 19.24 | 19.44 | 21.51 |
| Tax Burden | 0.69 | 0.68 | 0.68 | 0.66 | 0.71 |
| Interest Burden | 0.81 | 0.81 | 0.80 | 0.83 | 0.86 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.11 | 0.44 | 0.45 | 0.46 | 0.46 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 |
| Income Quality | 1.86 | 1.58 | 1.80 | 1.25 | 1.16 |
Currency in USD
